Literature DB >> 34236593

Comparison between extended transsphenoidal and transcranial surgery for craniopharyngioma: focus on hypothalamic function and obesity.

Marco Losa1, Pietro Mortini1, Alberto Luigi Gallotti2, Lina Raffaella Barzaghi1, Luigi Albano1, Marzia Medone1, Filippo Gagliardi1.   

Abstract

PURPOSE: Patients suffering from craniopharyngiomas currently have good survival rates, but long-term sequelae, such as development of obesity, worsen their quality of life. Optimal treatment is still controversial and changed during the decades, becoming less aggressive. Transcranial (TC) surgery was the first approach to be used, followed by extended transsphenoidal (eTNS) access. This study aims to compare the two approaches in terms of risk of hypothalamic damage leading to obesity.
METHODS: This is a monocentric retrospective analysis of post-puberal patients treated for primary craniopharyngioma. Postoperative obesity and percentual postsurgical BMI variation were considered proxy for hypothalamic function and used to fit regression models with basal BMI, type of surgery, tumor volume and hypothalamic involvement (anterior vs. anteroposterior).
RESULTS: No difference in radicality was observed between the two approaches; eTNS was more effective in ameliorating visual function but was significantly associated with CSF leaks. The TC approach was associated with a higher incidence of diabetes insipidus. Regression analysis showed only tumor volume and basal BMI resulted as independent predictors for both postoperative obesity (respectively, OR 1.15, P = 0.041, and OR 1.57, P < 0.001) and percentual BMI variation (respectively, + 0.92%, P = 0.005, and - 1.49%, P = 0.001).
CONCLUSIONS: Larger lesions portend a higher risk to develop postoperative obesity, independently of hypothalamic involvement. Interestingly, basal BMI is independent of lesional volume and is associated with postoperative obesity, but lesser postoperative BMI variation. The surgical approach does not influence the obesity risk. However, eTNS proves valid in managing large tumors with important hypothalamic invasion.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  BMI; Craniopharyngioma; Extended-transsphenoidal; Obesity; Transcranial

Mesh:

Year:  2021        PMID: 34236593     DOI: 10.1007/s11102-021-01171-2

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  26 in total

Review 1.  Craniopharyngioma surgery.

Authors:  Jürgen Honegger; Marcos Tatagiba
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

2.  The therapeutic efficacy of fractionated radiotherapy and gamma-knife radiosurgery for craniopharyngiomas.

Authors:  Chiman Jeon; Sejin Kim; Hyung Jin Shin; Do-Hyun Nam; Jung-Il Lee; Kwan Park; Jong Hyun Kim; ByungChan Jeon; Doo-Sik Kong
Journal:  J Clin Neurosci       Date:  2011-10-19       Impact factor: 1.961

3.  Craniopharyngiomas: a life-changing tumor.

Authors:  Pietro Mortini
Journal:  Endocrine       Date:  2016-12-16       Impact factor: 3.633

4.  Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series.

Authors:  Pietro Mortini; Marco Losa; Gabriella Pozzobon; Raffaella Barzaghi; Marco Riva; Stefania Acerno; Diana Angius; Giovanna Weber; Giuseppe Chiumello; Massimo Giovanelli
Journal:  J Neurosurg       Date:  2011-01-07       Impact factor: 5.115

5.  Surgery for pediatric craniopharyngiomas: is less more?

Authors:  Jörg Flitsch; Jens Aberle; Till Burkhardt
Journal:  J Pediatr Endocrinol Metab       Date:  2015-01       Impact factor: 1.634

6.  Long-term neurological, visual, and endocrine outcomes following transnasal resection of craniopharyngioma.

Authors:  Indro Chakrabarti; Arun P Amar; William Couldwell; Martin H Weiss
Journal:  J Neurosurg       Date:  2005-04       Impact factor: 5.115

Review 7.  Microsurgical removal of craniopharyngioma: endoscopic and transcranial techniques for complication avoidance.

Authors:  Saira Alli; Semra Isik; James T Rutka
Journal:  J Neurooncol       Date:  2016-05-19       Impact factor: 4.130

Review 8.  Endoscopic Endonasal Management of Craniopharyngioma.

Authors:  Brad E Zacharia; Muhamad Amine; Vijay Anand; Theodore H Schwartz
Journal:  Otolaryngol Clin North Am       Date:  2016-02       Impact factor: 3.346

Review 9.  Surgery for craniopharyngioma.

Authors:  Michael Buchfelder; Sven-Martin Schlaffer; Fuhua Lin; Andrea Kleindienst
Journal:  Pituitary       Date:  2013-03       Impact factor: 4.107

Review 10.  Surgical strategies and modern therapeutic options in the treatment of craniopharyngiomas.

Authors:  Pietro Mortini; Filippo Gagliardi; Nicola Boari; Marco Losa
Journal:  Crit Rev Oncol Hematol       Date:  2013-08-07       Impact factor: 6.312

View more
  2 in total

1.  Clinical Outcomes of Transcranial and Endoscopic Endonasal Surgery for Craniopharyngiomas: A Single-Institution Experience.

Authors:  Chuansheng Nie; Youfan Ye; Jingnan Wu; Hongyang Zhao; Xiaobing Jiang; Haijun Wang
Journal:  Front Oncol       Date:  2022-02-10       Impact factor: 6.244

Review 2.  Sleep Disorders in Patients With Craniopharyngioma: A Physiopathological and Practical Update.

Authors:  Andrea Romigi; Tiziana Feola; Simone Cappellano; Michelangelo De Angelis; Giacomo Pio; Marco Caccamo; Federica Testa; Giuseppe Vitrani; Diego Centonze; Claudio Colonnese; Vincenzo Esposito; Marie-Lise Jaffrain-Rea
Journal:  Front Neurol       Date:  2022-02-09       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.